USA: Key provisions of the FDA Reauthorization Act of 2017 relating to medical devices
On 18 August 2017, President Trump signed HR 2430, the FDA Reauthorization Act of 2017 (FDARA), which became Public Law No 115-521. Principally, FDARA re-authorises the Food and Drug Administration’s (FDA’s) user fee programmes, including the Medical Device User Fee…

